Royalty Pharma Plc Class A RPRX
NASDAQ · United States · Health Technology
$58.36+0.14 (+0.24%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-05 | 1.32 | 1.27 | +3.8% | $773.00M | +1.9% | -0.4%$57.48→$57.26 |
| Q1 2026 | 2026-05-06 | 1.30 | 1.22 | +6.6% | — | — | -0.5%$50.44→$50.20 |
| Q4 2025 | 2026-02-11 | 1.47 | 1.33 | +10.5% | — | — | +1.3%$44.21→$44.80 |
| Q3 2025 | 2025-11-05 | 1.17 | 1.11 | +5.4% | — | — | +7.8%$37.84→$40.78 |
| Q4 2024 | 2025-02-11 | 1.15 | 1.05 | +9.5% | — | — | — |
| Q4 2023 | 2024-02-15 | 1.52 | 1.00 | +52.0% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.